Study finds children with residual amblyopia did not find an advantage with levodopa

A recent study of children ages 7 to 12 with residual amblyopia did not find an advantage with the use of levodopa compared with a placebo group, according to Michael X. Repka, MD, MBA.

Baltimore-A recent study of children ages 7 to 12 with residual amblyopia did not find an advantage with the use of levodopa compared with a placebo group, according to Michael X. Repka, MD, MBA. 

 

Read the results of the study here.

Related Videos
Related Content

Ophthalmology group to pay nearly $3 million to resolve optometrist referral kickback allegations

March 29th 2023

Practical management EP 9: Understanding the difference between branding & marketing

March 24th 2023

3-week therapeutics for MGD equivalent to 6-week treatment in efficacy and adverse events

March 27th 2023

Practical management EP 8: First steps to increase net revenue

March 16th 2023

This week in optometry: March 20-March 24

March 25th 2023

Alzheimer’s disease may be detected in retinal proteins

March 24th 2023

Ophthalmology group to pay nearly $3 million to resolve optometrist referral kickback allegations

March 29th 2023

Practical management EP 9: Understanding the difference between branding & marketing

March 24th 2023

3-week therapeutics for MGD equivalent to 6-week treatment in efficacy and adverse events

March 27th 2023

Practical management EP 8: First steps to increase net revenue

March 16th 2023

This week in optometry: March 20-March 24

March 25th 2023

Alzheimer’s disease may be detected in retinal proteins

March 24th 2023

Ophthalmology group to pay nearly $3 million to resolve optometrist referral kickback allegations

March 29th 2023

Practical management EP 9: Understanding the difference between branding & marketing

March 24th 2023

3-week therapeutics for MGD equivalent to 6-week treatment in efficacy and adverse events

March 27th 2023

Practical management EP 8: First steps to increase net revenue

March 16th 2023

This week in optometry: March 20-March 24

March 25th 2023

Alzheimer’s disease may be detected in retinal proteins

March 24th 2023
© 2023 MJH Life Sciences

All rights reserved.